post-bg-486
calendary March 6, 2024

Gene therapy may help treat congenital deafness

According to the results of a study by the Chinese company Refreshgene Therapeutics, as part of a clinical trial of AAV1-hOTOF gene therapy, hearing was restored to 5 out of 6 children with congenital deafness.

The clinical trial, conducted at the Massachusetts Medical Center for Vision and Hearing (MEE) in Boston, enrolled six children aged one to 18 years with autosomal recessive nonsyndromic deafness type 9 (DFNB9), caused by a mutation in the OTOF gene. According to the researchers, a defect in this gene leads to dysfunction of the otoferlin protein, whose main function is to transmit sound signals from the ear to the brain.

Refreshgene Therapeutics has developed a drug that is an OTOF transgene on adeno-associated virus serotype 1 (AAV1), intended for one-time injection into patients' inner ear at different dosages. After drug administration, patients were examined for 26 weeks.

6 months after therapy, 5 out of 6 patients had restored hearing and improved speech understanding.

No patients experienced any serious adverse events during the study, but 46 adverse events did occur, including a decrease in neutrophil counts in one study participant.

However, according to the results of the study, the drug was found to be effective and safe for the treatment of children with congenital deafness.

According to the researchers, this is the first clinical trial to study the effectiveness of gene therapy to treat DFNB9. In the future, it is planned to organize larger studies involving a larger number of patients in order to verify the effectiveness of this treatment method.

According to WHO: “More than 5% of the world's population, or 430 million people, require rehabilitation to address disabling hearing loss (432 million adults and 34 million children). It is estimated that by 2050, more than 700 million people, or one in ten, will have disabling hearing loss.

“Disabling” hearing loss in the better-hearing ear is greater than 35 decibels (dB). Almost 80% of these people live in low- and middle-income countries. Hearing loss is more widespread among older people, with the problem affecting more than 25% of people over the age of 60.”

References:
  1. https://pharmvestnik.ru/content/news/Kitaiskaya-kompaniya-predstavila-obnadejivaushie-rezultaty-gennoi-terapii-ot-vrojdennoi-gluhoty.html
  2. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02874-X/fulltext
  3. https://www.who.int/ru/news-room/fact-sheets/detail/deafness-and-hearing-loss

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE